UNICYCIVE THERAPEUTICS, INC. Preferred Stock Convertible Shares Issuable
UNICYCIVE THERAPEUTICS, INC. (UNCY) had Preferred Stock Convertible Shares Issuable of 1.00 thousand shares as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Notes › Stockholders' Equity Note › Class of Stock Disclosures › Preferred Stock, Number of Shares, Par Value and Other Disclosure › Features of Convertible Preferred Stock
us-gaap:PreferredStockConvertibleSharesIssuable · last filed 2025-05-14
- 2025-03-31: Preferred Stock Convertible Shares Issuable 1.00K shares.
- 2024-12-31: Preferred Stock Convertible Shares Issuable 1.00K shares.
- 2024-09-30: Preferred Stock Convertible Shares Issuable 1.00M shares.
| Period end | Preferred Stock Convertible Shares Issuable |
|---|---|
| 2025-03-31 | 1.00K shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 1.00K shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 1.00M shares 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |